Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (831-840 of 903) with videos related to

Pageof 91
Sort By:
Neurobiology of Aging|June 13, 2016
ABCA7 p.G215S as potential protective factor for Alzheimer's diseaseCeleste Sassi, Michael A Nalls, Perry G Ridge, et al.
Neurology|July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic CarriersEmma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2018
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementiaRosalinde E R Slot, Sietske A M Sikkes, Johannes Berkhof, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Human Molecular Genetics|July 17, 2014
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's diseaseAlfredo Ramirez, Wiesje M van der Flier, Christine Herold, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
BMC Geriatrics|November 28, 2018
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ studyNienke Legdeur, Maryam Badissi, Stephen F Carter, et al.
Pageof 91

Showing results (831-840 of 903) with videos related to

Sort By:
Pageof 91
Neurobiology of Aging|June 13, 2016
ABCA7 p.G215S as potential protective factor for Alzheimer's diseaseCeleste Sassi, Michael A Nalls, Perry G Ridge, et al.
Neurology|July 2, 2021
[<sup>18</sup>F]Flortaucipir PET Across Various <i>MAPT</i> Mutations in Presymptomatic and Symptomatic CarriersEmma E Wolters, Janne M Papma, Sander C J Verfaillie, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 18, 2018
Subjective cognitive decline and rates of incident Alzheimer's disease and non-Alzheimer's disease dementiaRosalinde E R Slot, Sietske A M Sikkes, Johannes Berkhof, et al.
Frontiers in Neurology|November 4, 2015
The Central Biobank and Virtual Biobank of BIOMARKAPD: A Resource for Studies on Neurodegenerative DiseasesBabette L R Reijs, Charlotte E Teunissen, Nikolai Goncharenko, et al.
Human Molecular Genetics|July 17, 2014
SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's diseaseAlfredo Ramirez, Wiesje M van der Flier, Christine Herold, et al.
Brain Communications|September 21, 2020
Single-subject grey matter network trajectories over the disease course of autosomal dominant Alzheimer's diseaseLisa Vermunt, Ellen Dicks, Guoqiao Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2016
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteriaBruno Dubois, Harald Hampel, Howard H Feldman, et al.
Molecular Psychiatry|February 17, 2022
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammationAlexander Neumann, Fahri Küçükali, Isabelle Bos, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
BMC Geriatrics|November 28, 2018
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ studyNienke Legdeur, Maryam Badissi, Stephen F Carter, et al.
Pageof 91